Immediate Impact
53 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Brian Elliott being referenced
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
2021 Standout
Subcutaneous Epcoritamab Induces Complete Responses with an Encouraging Safety Profile across Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Subtypes, Including Patients with Prior CAR-T Therapy: Updated Dose Escalation Data
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Brian Elliott | 339 | 248 | 112 | 31 | 456 | |
| M. Dorreen | 150 | 177 | 49 | 23 | 388 | |
| Ivo Radman | 140 | 151 | 54 | 42 | 407 | |
| Ryan Jacobs | 164 | 179 | 117 | 56 | 473 | |
| A E Dewar | 108 | 183 | 87 | 33 | 479 | |
| Letizia Gandolfi | 196 | 404 | 83 | 28 | 491 | |
| László Váróczy | 83 | 219 | 48 | 44 | 411 | |
| Barbara Jezeršek Novaković | 160 | 178 | 59 | 41 | 387 | |
| Leanne Berkahn | 147 | 247 | 44 | 35 | 458 | |
| Francesco Grimaldi | 120 | 110 | 45 | 29 | 449 | |
| Annunziata Manna | 173 | 224 | 25 | 29 | 475 |
All Works
Login with ORCID to disown or claim papers
Loading papers...